BioAge Labs, Inc. (BIOA) Insider Trading

Over the last 3 months, BIOA insiders made 0 open-market buys and 2 sales, a net sale of -$1.6M (SEC Form 4). Over the last 6 months, 88 institutions increased and 53 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
2
Net (3m)
-$1.6M
Insider trades by month Buys Sells
Mar
Dec
Jan
Feb
Apr
Jul
Context3-month price +38.6%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jul 1, 2026Barton Shaneofficer: Principal Accounting OfficerOption4,065$4.30
Jul 1, 2026Barton Shaneofficer: Principal Accounting OfficerOption4,000$8.39
Jul 1, 2026Barton Shaneofficer: Principal Accounting OfficerOption4,290$10.85
Jul 1, 2026Barton Shaneofficer: Principal Accounting OfficerSell42,350$25.21
Jul 1, 2026Barton Shaneofficer: Principal Accounting OfficerOption9,301$10.85
Jul 1, 2026Barton Shaneofficer: Principal Accounting OfficerOption7,261$8.39
Jul 1, 2026Barton Shaneofficer: Principal Accounting OfficerOption8,958$4.30
Jul 1, 2026Barton Shaneofficer: Principal Accounting OfficerOption14,198$4.38
Jul 1, 2026Barton Shaneofficer: Principal Accounting OfficerSell20,216$25.19
Jul 1, 2026Barton Shaneofficer: Principal Accounting OfficerOption7,861$4.38
Jun 12, 2026Pande Vijay SatyananddirectorGrant22,000$15.48
Jun 12, 2026Hemrajani RekhadirectorGrant22,000$15.48
Jun 12, 2026HEALY JAMESdirectorGrant22,000$15.48
Jun 12, 2026ENRIGHT PATRICK GdirectorGrant22,000$15.48
Jun 12, 2026Davidson Michael H.directorGrant22,000$15.48
Jun 12, 2026GARNIER JEAN PIERREdirectorGrant22,000$15.48
Apr 24, 2026GOLDSTEIN DOV A MDofficer: Chief Financial OfficerOption3,542$4.38
Apr 3, 2026RUBIN PAUL Dofficer: Chief Medical OfficerOption3,383$6.57
Apr 3, 2026RUBIN PAUL Dofficer: Chief Medical OfficerSell8,820$17.81
Apr 3, 2026RUBIN PAUL Dofficer: Chief Medical OfficerOption5,437$4.11
Feb 19, 2026RUBIN PAUL Dofficer: Chief Medical OfficerGrant110,000$19.63
Feb 19, 2026Barton Shaneofficer: Principal Accounting OfficerGrant45,000$19.63
Feb 19, 2026Morgen Ericdirector, officer: Chief Operating OfficerGrant110,000$19.63
Feb 19, 2026Morgen Ericdirector, officer: Chief Operating OfficerGrant12,500$19.63
Feb 19, 2026Fortney Kristendirector, officer: Chief Executive OfficerGrant330,000$19.63
Feb 19, 2026GOLDSTEIN DOV A MDofficer: Chief Financial OfficerGrant110,000$19.63
Feb 3, 2026GOLDSTEIN DOV A MDofficer: Chief Financial OfficerOption3,541$4.38
Feb 3, 2026RUBIN PAUL Dofficer: Chief Medical OfficerOption5,433$4.11
Feb 3, 2026RUBIN PAUL Dofficer: Chief Medical OfficerOption2,000$6.57
Feb 3, 2026RUBIN PAUL Dofficer: Chief Medical OfficerSell7,433$18.75

Source: BIOA SEC Form 4 filings, latest Jul 1, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their BIOA positions over the last 6 months (SEC Form 13F).

Increased
88
New positions
79
Reduced
53
Sold out
26
Largest moves
InstitutionActionSharesFiled
JANUS HENDERSON GROUP PLCIncreased4.2MMay 18, 2026
AH CAPITAL MANAGEMENT, L.L.C.Unchanged3.2MMay 15, 2026
AH CAPITAL MANAGEMENT, L.L.C.Unchanged3.2MFeb 17, 2026
CORMORANT ASSET MANAGEMENT, LPIncreased2.9MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2.7MMay 15, 2026
SOFINNOVA INVESTMENTS, INC.Unchanged2.3MMay 15, 2026
SOFINNOVA INVESTMENTS, INC.Unchanged2.3MFeb 13, 2026
BLACKROCK, INC.Increased2.3MMay 13, 2026
CORMORANT ASSET MANAGEMENT, LPReduced2.0MFeb 17, 2026
OCTAGON CAPITAL ADVISORS LPIncreased1.7MMay 15, 2026
RA CAPITAL MANAGEMENT, L.P.New Position1.7MMay 15, 2026
OCTAGON CAPITAL ADVISORS LPNew Position1.6MFeb 17, 2026
BLACKROCK, INC.Increased1.5MFeb 12, 2026
VANGUARD GROUP INCReduced1.4MJan 29, 2026
BALYASNY ASSET MANAGEMENT L.P.New Position1.3MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.